Clinical aspects and prospects of using DPP-4 inhibitors
Type 2 diabetes mellitus is a serious disease associated with the development of severe complications. Recent advances in diabetology are related to hormone therapy. The mechanism of action of DPP-4 inhibitors is discussed. The results of clinical studies of the efficacy and safety of gosogliptine a...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2019-08-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/3111 |
id |
doaj-a1c25880fedd4af7877f06b12d25c7ea |
---|---|
record_format |
Article |
spelling |
doaj-a1c25880fedd4af7877f06b12d25c7ea2021-07-28T13:29:42ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902019-08-0104242910.21518/2079-701X-2019-4-24-293019Clinical aspects and prospects of using DPP-4 inhibitorsE. V. Biryukova0Federal State Budgetary Educational Institution of the Higher Education «Moscow State University of Medicine and Dentistry named after A.I. Yevdokimov» of the Ministry of Healthcare of the Russian FederationType 2 diabetes mellitus is a serious disease associated with the development of severe complications. Recent advances in diabetology are related to hormone therapy. The mechanism of action of DPP-4 inhibitors is discussed. The results of clinical studies of the efficacy and safety of gosogliptine are presented.https://www.med-sovet.pro/jour/article/view/3111type 2 diabetes mellitusvascular complicationssugar-reducing therapydpp-4 inhibitorsgosogliptine |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
E. V. Biryukova |
spellingShingle |
E. V. Biryukova Clinical aspects and prospects of using DPP-4 inhibitors Медицинский совет type 2 diabetes mellitus vascular complications sugar-reducing therapy dpp-4 inhibitors gosogliptine |
author_facet |
E. V. Biryukova |
author_sort |
E. V. Biryukova |
title |
Clinical aspects and prospects of using DPP-4 inhibitors |
title_short |
Clinical aspects and prospects of using DPP-4 inhibitors |
title_full |
Clinical aspects and prospects of using DPP-4 inhibitors |
title_fullStr |
Clinical aspects and prospects of using DPP-4 inhibitors |
title_full_unstemmed |
Clinical aspects and prospects of using DPP-4 inhibitors |
title_sort |
clinical aspects and prospects of using dpp-4 inhibitors |
publisher |
Remedium Group LLC |
series |
Медицинский совет |
issn |
2079-701X 2658-5790 |
publishDate |
2019-08-01 |
description |
Type 2 diabetes mellitus is a serious disease associated with the development of severe complications. Recent advances in diabetology are related to hormone therapy. The mechanism of action of DPP-4 inhibitors is discussed. The results of clinical studies of the efficacy and safety of gosogliptine are presented. |
topic |
type 2 diabetes mellitus vascular complications sugar-reducing therapy dpp-4 inhibitors gosogliptine |
url |
https://www.med-sovet.pro/jour/article/view/3111 |
work_keys_str_mv |
AT evbiryukova clinicalaspectsandprospectsofusingdpp4inhibitors |
_version_ |
1721273736133345280 |